FDG-PET/CT: metabolically active solitary lesion in the gluteal region subcutaneously in a patient with breast cancer - granuloma or metastasis? [0.03%]
18FDG-PET/CT：乳腺癌患者臀部皮下代谢活跃的孤立病灶-肉芽肿还是转移？
Z Řehák,M Palácová,S Soboličová et al.
Z Řehák et al.
Second recurrence of breast cancer 36 years after initial surgery and 18 years after the first recurrence - an extremely rare case [0.03%]
右侧乳腺癌第二次复发——相隔36年初始肿瘤切除和18年的第一次复发后极为罕见的病例报告
Y Maezawa,T Terada,H Kobayashi et al.
Y Maezawa et al.
Background: Breast cancer is a one of the most common causes of cancer death in the world. Late recurrence is a notable characteristic of this disease. Ca...
Intravascular propagation of adenomyosis within the blood vessels of the myometrium and uterine leiomyoma in a patient harboring germline mutation in the fumarate hydratase gene - a rare finding simulating malignancy [0.03%]
富马酸水合酶基因生殖细胞突变患者的子宫肌层和平滑肌瘤内子宫腺肌病的血管内播散——一种罕见的类似恶性肿瘤的表现形式
V Bartoš,B Hudec,E Baloghová
V Bartoš
Background: Hereditary leiomyomatosis and renal cell carcinoma is a rare genetic disorder characterized by a predisposition to the development of multiple cutaneous and uterinne leiomyomas with a potential for malignant t...
Circulating tumor DNA as a biomarker for the prediction of minimal residual disease and the individualization of adjuvant therapy in colorectal cancer - a review of current evidence and perspectives [0.03%]
循环肿瘤DNA在结直肠癌微小残留病预测及术后个体化治疗中的生物标记价值：现有证据和观点的回顾分析
A Pirshtuk,T Büchler,V Vymetálková
A Pirshtuk
Background: Colorectal cancer (CRC) remains one of the most common malignancies in the Czech Republic. Despite advances in surgical treatment, the risk of recurrence persists, mainly due to minimal residual disease (MRD)....
A Nohejlová Medková,P Pacas,K Kopečková
A Nohejlová Medková
Background: Ewing sarcoma belongs to the family of undifferentiated small round cell sarcomas of bone and soft tissue. It is characterized by a gene fusion involving EWSR1 and an ETS-family transcription factor gene. In 8...
Treatment of Castleman disease from the perspective of the year 2026 [0.03%]
从2026年的视角看待Castleman病的治疗
Z Adam,Z Řehák,I Boichuk et al.
Z Adam et al.
Background: New drugs are continuously entering clinical practice, and therefore opinions on the treatment of Castleman disease are constantly being updated. The text provides information on the treatment of this disease ...
Experiencing secondary losses in cancer patients concerning disease trajectory [0.03%]
癌症患者的病情轨迹的次级损失体验
O Klepáčková,M Tomka
O Klepáčková
Background: Oncological disease is characterized not only by the initial loss of health resulting from the diagnosis itself, but also by secondary losses that affect the areas of physical, emotional, spiritual, and social...
A Kapinová,I Kašubová,M Šarlinová et al.
A Kapinová et al.
Background: Whole plant foods are a rich source of a wide range of bioactive functional substances - phytochemicals, with extensive additive and/or synergistic effects within the process of carcinogenesis. Thanks to the g...
MET exon 14 skipping gene-positive lung adenocarcinoma associated with atypical adenomatous hyperplasia in lungs and metachronous lung adenocarcinoma [0.03%]
肺腺癌合并肺不典型腺瘤样增生和异时性肺腺癌一例及其基因突变分析
H Sunabe,Y Maezawa,T Shiozawa et al.
H Sunabe et al.
Background: Recently, there has been interest in the CT imaging characteristics of lung cancer positive for mesenchymal-epithelial transition (MET) exon14 skipping mutation. Herein, we present a patient with MET exon 14 s...
Cardiac metastasis of urothelial carcinoma mimicking ST-elevation myocardial infarction [0.03%]
类似急性心肌梗死的尿路上皮癌心脏转移灶病例报告
L Chaloupková,V Suchánek,T Büchler
L Chaloupková
Background: Urothelial carcinoma (UC) is the second most common malignancy of the urinary tract. While distant metastases are relatively frequent in advanced UC, cardiac involvement is exceedingly rare and typically asymp...